Although we cannot provide direct evidence that Tocilizumab treatment is useful in patients with COVID-19 and lymphomas, our results confirm that IL-6 plays a role in the COVID-19 disease and anti-cytokine treatment should be further explored. This evidence concerns the gene IL6 and COVID-19.